Back to MW MARSHALL WACE, LLP

GHGH
22 quarters

Position history for MWMARSHALL WACE, LLP's holdings in Guardant Health, Inc.

MARSHALL WACE, LLP holds 185,150 shares of GH (Guardant Health, Inc.), worth $27.8M as of 2026-Q2. This is a new position. GH represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$27.8M

Current Shares

185,150

Total Value Change

-$19.9M

Total Shares Change

-499,758

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
185,150
-
$27.8M0.0%$150.03
40
2026-Q1
Exited
0
-100.0%
$00.0%$93.30
0
2025-Q4
Decreased
171,206
-29.1%
$17.5M0.0%$100.60
0
2025-Q3
New
241,306
-
$15.1M0.0%$61.99
39
2025-Q2
Exited
0
-100.0%
$00.0%$50.86
0
2025-Q1
Increased
176,533
+450.2%
$7.5M0.0%$43.14
44
2024-Q4
New
32,085
-
$980,1970.0%$30.54
35
2024-Q2
Exited
0
-100.0%
$00.0%$28.88
0
2024-Q1
New
119,878
-
$2.5M0.0%$20.63
36
2023-Q3
Exited
0
-100.0%
$00.0%$29.64
0
2023-Q2
Increased
353,333
+1615.2%
$12.6M0.0%$36.29
45
2023-Q1
Increased
20,600
+157.7%
$482,8640.0%$22.92
39
2022-Q4
New
7,994
-
$217,4370.0%$27.20
32
2022-Q1
Exited
0
-100.0%
$00.0%$66.99
0
2021-Q4
New
3,954
-
$396,0000.0%$100.23
33
2021-Q3
Exited
0
-100.0%
$00.0%$121.10
0
2021-Q2
Increased
336,204
+610.9%
$41.8M0.2%$127.79
56
2021-Q1
Decreased
47,291
-95.0%
$7.2M0.0%$146.79
0
2020-Q4
Increased
946,882
+1.6%
$122M0.7%$126.14
43
2020-Q3
Decreased
931,582
-38.6%
$104.1M0.7%$111.24
0
2020-Q2
Increased
1.5M
+121.7%
$123.2M0.9%$80.00
69
2020-Q1
New
684,908
-
$47.7M0.5%$71.25
48

Other major holders of GH: BNP PARIBAS FINANCIAL MARKETS, SB INVESTMENT ADVISERS (UK) LTD

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used